Recent Posts
- The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity
- The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market.
- From Patent Risk to Strategic Clarity: How Docana Built an IP Strategy with PatentVest
- Using AI In Your Inventive Process? Proceed to Patent, But Carefully
- The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine
Archives
- June 2026
- April 2026
- March 2026
- February 2026
- January 2026
- October 2025
- August 2025
- July 2025
- June 2025
- May 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- July 2024
- June 2024
- May 2024
- April 2024
- February 2024
- January 2024
- November 2023
- October 2023
- June 2023
- May 2023
- November 2022
- October 2022
- August 2022
- July 2022
- June 2022
Recent Comments